Why the study?
Despite recommendations, historically a third of suspected ACS patients under EMS care did not receive a prehospital ECG, prompting an updated evaluation of care and outcomes in the primary PCI era.
Does prehospital 12-lead ECG improve 30-day mortality and reperfusion rates in patients presenting to EMS with suspected ACS?
Does prehospital 12-lead ECG improve 30-day mortality and reperfusion rates in patients presenting to EMS with suspected ACS?
Answers are grounded in this paper and cite their sources.
This protocol outlines a mixed-methods study to evaluate the current use, clinical impact, and barriers to implementation of prehospital 12-lead ECGs for suspected ACS in the primary PCI era.
Introduction: Use of the prehospital 12-lead ECG (PHECG) is recommended in patients presenting to emergency medical services (EMS) with suspected acute coronary syndrome (ACS). Prior research found that although PHECG use was associated with improved 30-day survival, a third of patients (typically women, the elderly and those with comorbidities) under EMS care did not receive a PHECG.The overall aim of the PHECG2 study is to update evidence on care and outcomes for patients eligible for PHECG, specifically addressing the following research questions: (1) Is there a difference in 30-day mortality, and in reperfusion rate, between those who do and those who do not receive PHECG? (2) Has the proportion of eligible patients who receive PHECG changed since the introduction of primary percutaneous coronary intervention networks? (3) Are patients that receive PHECG different from those that do not in terms of social and demographic factors, or prehospital clinical presentation? (4) What factors influence EMS clinicians' decisions to perform PHECG? Methods and analysis: This is an explanatory, mixed-method study comprising four work packages (WPs). WP1 is a population-based, linked-data analysis of a national ACS registry (Myocardial Ischaemia National Audit Project). WP2 is a retrospective chart review of patient records from three large regional EMS. WP3 comprises focus groups of EMS personnel. WP4 will synthesise findings from WP1-3 to inform the development of an intervention to increase PHECG uptake. Ethics and dissemination: The study has been approved by the London-Hampstead Research Ethics Committee (ref: 18LO1679). Findings will be disseminated through feedback to participating EMS, conference presentations and publication in peer-reviewed journals. Trial registration number: NCT03699137.
No takes yet. Share an insight, caveat, or question.
Gavalova et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: